BMC Setting New Standard for Prostate Cancer Care
Prostate cancer is the second most lethal cancer among American men and is also one of the most prevalent. According to the National Cancer Institute, one in six men will be diagnosed with cancer of the prostate during their lifetime.
Early detection and treatment continue to offer the best chance for survival, especially for those men deemed high risk for the disease, including African American men and men with a family history of prostate cancer.
With 35 years of experience in the study and treatment of urological diseases, Boston Medical Center offers new non-invasive diagnostic tools and customized treatment plans to control prostate cancer and manage its impact on patients’ quality of life. Renowned subspecialists in BMC’s Department of Urology subscribe to a personalized, multidisciplinary approach to patient care.
“Every patient is seen by an attending urologist,” explains Chief of Urology Richard K. Babayan, MD, an American Urological Association research scholar. “We maintain this one-to-one relationship throughout diagnosis and treatment, and we coordinate the patient’s care across disciplines.”
Dr. Babayan and his team offer patients a variety of diagnostic and treatment options that provide the best long-term outlook, including active surveillance, surgery, radiation, chemotherapy, and hormone therapy.
BMC offers diagnostic advancements such as endorectal MRI technology, which can help guide treatment performs cryosurgery, another minimally invasive treatment option.
Numerous departments within the hospital collaborate closely to improve patient outcomes. BMC specialists in sexual medicine, incontinence, endocrinology, integrative medicine, nutrition, social work and psychiatry can help mitigate common side effects associated with prostate cancer and its treatment.
For more information or to schedule an appointment call 877.781.4763.